<DOC>
	<DOCNO>NCT01064362</DOCNO>
	<brief_summary>Arixtra ( fondaparinux sodium ) first selective Factor Xa inhibitor market . As anticoagulant , important adverse event associate Arixtra use haemorrhage . Previous study use clinical trial observational data show difference risk haemorrhage patient treat Arixtra compare ( low molecular weight heparin ) LMWHs . This study ass risk haemorrhage major orthopaedic surgery patient ( hip fracture surgery and/or hip/knee replacement surgery ) treat either Arixtra LMWH thromboprophylaxis provide additional observational data European country strengthen comprehensive review haemorrhage post-marketing safety Arixtra . All patient age 18 year old primary discharge diagnosis hip fracture surgery and/or hospitalization hip and/or knee replacement surgery PHARMO RLS database Netherlands eligible participation . For study inclusion patient must receive either Arixtra LMWH initial in-hospital thromboprophylactic agent least three month PHARMO RLS database cohort entry date . Patients history hospitalization haemorrhage , renal failure liver failure past 3 month exclude . Descriptive statistic , include gender , age , length treatment , co-morbidities , concomitant medication , covariates calculate . Data study obtain different register PHARMO medical record linkage system ( PHARMO RLS ) Netherlands . The PHARMO medical record linkage system population-based patient-centric data track system include high quality complete information patient demographic , drug dispensing , hospital morbidity record approximately 2.3 million community-dwelling inhabitant 48 geo-demographic area Netherlands . The PHARMO register link patient level contain unprecedented accurate complete information require study . The patient database contain drug dispense data U-Expo database encode accord standard base upon Z-Index drug database ( www.z-index.nl ) . Therefore , possible identify classify drug use time , basis national international classification schemes well basis individual active ingredient administration form . Of dispensed drug , Anatomical Therapeutic Chemical ( ATC ) code , dispense date , prescriber , prescribe dosage regimen , dispense quantity , cost estimate legend duration use available . The hospital pharmacy database comprise hospital pharmacy data collect grow number non-academic hospital Netherlands . Currently , data collect patient level one million patient representative sample non-academic hospital pharmacy scatter Netherlands . The hospital pharmacy database include data in-patient medication order type drug , dose , time administration duration use . The Dutch Medical Register ( LMR ) data source comprise hospital admission Netherlands ( www.prismant.nl ) . These record include detailed information concern primary secondary discharge diagnosis , diagnostic , surgical treatment procedure , type frequency consultation medical specialist date hospital admission discharge . All diagnosis cod accord International Classification Diseases , 9th edition ( ICD-9-CM ) . Currently , data December 2008 available .</brief_summary>
	<brief_title>Hemorrhage Risk Prescribed Arixtra</brief_title>
	<detailed_description>Patients recruit enrolled study . This study retrospective observational study . Data medical record insurance claim database anonymised use develop patient cohort . All diagnosis treatment record course routine medical practice .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Age 18 year old ; Treatment either Arixtra LMWH initial inhospital thromboprophylactic agent ; At least three month history PHARMO RLS database cohort entry date Hospitalization haemorrhage , renal failure liver failure 3 month cohort entry date</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Haemorrhage</keyword>
	<keyword>Thromboprophylaxis</keyword>
</DOC>